81 related articles for article (PubMed ID: 28405004)
21. Use of chemical auxiliaries to control p450 enzymes for predictable oxidations at unactivated C-h bonds of substrates.
Auclair K; Polic V
Adv Exp Med Biol; 2015; 851():209-28. PubMed ID: 26002737
[TBL] [Abstract][Full Text] [Related]
22. [Engineering the enantioselectivity of biocatalysts].
Zhu D; Wu Q
Sheng Wu Gong Cheng Xue Bao; 2009 Dec; 25(12):1770-8. PubMed ID: 20352950
[TBL] [Abstract][Full Text] [Related]
23. Engineered P450 biocatalysts show improved activity and regio-promiscuity in aromatic nitration.
Zuo R; Zhang Y; Jiang C; Hackett JC; Loria R; Bruner SD; Ding Y
Sci Rep; 2017 Apr; 7(1):842. PubMed ID: 28405004
[TBL] [Abstract][Full Text] [Related]
24. Direct aromatic nitration by bacterial P450 enzymes.
Chen M; Petriti V; Mondal A; Jiang Y; Ding Y
Methods Enzymol; 2023; 693():307-337. PubMed ID: 37977734
[TBL] [Abstract][Full Text] [Related]
25. The Ferric-Superoxo Intermediate of the TxtE Nitration Pathway Resists Reduction, Facilitating Its Reaction with Nitric Oxide.
Martin CP; Chen M; Martinez MF; Ding Y; Caranto JD
Biochemistry; 2021 Aug; 60(31):2436-2446. PubMed ID: 34319079
[TBL] [Abstract][Full Text] [Related]
26. Expanding the Substrate Scope of Nitrating Cytochrome P450 TxtE by Active Site Engineering of a Reductase Fusion.
Saroay R; Roiban GD; Alkhalaf LM; Challis GL
Chembiochem; 2021 Jul; 22(13):2262-2265. PubMed ID: 33851500
[TBL] [Abstract][Full Text] [Related]
27. Direct Aromatic Nitration System for Synthesis of Nitrotryptophans in Escherichia coli.
Zuo R; Ding Y
ACS Synth Biol; 2019 Apr; 8(4):857-865. PubMed ID: 30865826
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a regioselectivity switch in nitrating P450s guided by molecular dynamics simulations and Markov models.
Dodani SC; Kiss G; Cahn JK; Su Y; Pande VS; Arnold FH
Nat Chem; 2016 May; 8(5):419-25. PubMed ID: 27102675
[TBL] [Abstract][Full Text] [Related]
29. Synthetic approaches to the 2014 new drugs.
Flick AC; Ding HX; Leverett CA; Kyne RE; Liu KK; Fink SJ; O'Donnell CJ
Bioorg Med Chem; 2016 May; 24(9):1937-80. PubMed ID: 27020685
[TBL] [Abstract][Full Text] [Related]
30. Ordered chimerogenesis applied to CYP2B P450 enzymes.
Lautier T; Urban P; Loeper J; Jezequel L; Pompon D; Truan G
Biochim Biophys Acta; 2016 Jul; 1860(7):1395-403. PubMed ID: 27015760
[TBL] [Abstract][Full Text] [Related]
31. An artificial self-sufficient cytochrome P450 directly nitrates fluorinated tryptophan analogs with a different regio-selectivity.
Zuo R; Zhang Y; Huguet-Tapia JC; Mehta M; Dedic E; Bruner SD; Loria R; Ding Y
Biotechnol J; 2016 May; 11(5):624-32. PubMed ID: 26743860
[TBL] [Abstract][Full Text] [Related]
32. Synthetic approaches to the 2013 new drugs.
Ding HX; Leverett CA; Kyne RE; Liu KK; Fink SJ; Flick AC; O'Donnell CJ
Bioorg Med Chem; 2015 May; 23(9):1895-922. PubMed ID: 25797159
[TBL] [Abstract][Full Text] [Related]
33. Industrial applications of enzyme biocatalysis: Current status and future aspects.
Choi JM; Han SS; Kim HS
Biotechnol Adv; 2015 Nov; 33(7):1443-54. PubMed ID: 25747291
[TBL] [Abstract][Full Text] [Related]
34. Structural, functional, and spectroscopic characterization of the substrate scope of the novel nitrating cytochrome P450 TxtE.
Dodani SC; Cahn JK; Heinisch T; Brinkmann-Chen S; McIntosh JA; Arnold FH
Chembiochem; 2014 Oct; 15(15):2259-67. PubMed ID: 25182183
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in biocatalyst discovery, development and applications.
Yang G; Ding Y
Bioorg Med Chem; 2014 Oct; 22(20):5604-12. PubMed ID: 25042559
[TBL] [Abstract][Full Text] [Related]
36. P-LinK: A method for generating multicomponent cytochrome P450 fusions with variable linker length.
Belsare KD; Ruff AJ; Martinez R; Shivange AV; Mundhada H; Holtmann D; Schrader J; Schwaneberg U
Biotechniques; 2014 Jul; 57(1):13-20. PubMed ID: 25005689
[TBL] [Abstract][Full Text] [Related]
37. Delamanid: first global approval.
Ryan NJ; Lo JH
Drugs; 2014 Jun; 74(9):1041-5. PubMed ID: 24923253
[TBL] [Abstract][Full Text] [Related]
38. Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations.
Bernhardt R; Urlacher VB
Appl Microbiol Biotechnol; 2014; 98(14):6185-203. PubMed ID: 24848420
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
